About Us
Discover how Evidentic removes barriers to pharmaceutical research and accelerates early-stage drug development.
Our Mission
At Evidentic, our mission is to remove barriers that slow down pharmaceutical research and give scientists reliable, affordable access to licensed molecules. By providing small aliquots of clinically tested, EMA/FDA-certified therapeutics, we enable researchers to work with the real molecules that matter—without the cost and complexity of sourcing full medicines.
This approach empowers scientists at universities, startups, and global pharmaceutical companies alike to focus on discovery rather than logistics. By accelerating early-stage drug development, we help turn bold ideas into potential therapies faster, ultimately advancing innovation and improving global health.
A Word from our Founder
When I founded Evidentic, my mission was to remove one of the biggest obstacles in drug research: access to licensed molecules. Traditionally, scientists struggled to obtain the compounds they needed, slowing down discoveries that could improve or even save lives. Evidentic changes this by providing small aliquots of clinically tested, EMA/FDA -certified medicines —making vital molecules available, affordable, and practical for research.
This simple but powerful model accelerates R&D by reducing costs and ensuring researchers can focus on science, not sourcing. By enabling innovation at earlier stages, we help companies explore bold new therapies that might otherwise never be developed.
Today, with over 550 customers worldwide, Evidentic is proving how smarter access to medicines can speed up breakthroughs and advance global health.
